Related Experiment Video
Updated: Jun 28, 2025

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
Published on: January 16, 2015
Correlation Between HIF1-A Expression and Airway Remodeling in COPD
Lingfang Tan1, Xuefeng Yang2, Jianxin Zhang3
1The Nanhua Affiliated Hospital, Department of Respiratory Physicians, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, People's Republic of China.
Hypoxia-inducible factor 1-alpha (HIF-1α) is elevated in chronic obstructive pulmonary disease (COPD) patients, correlating with airway remodeling. This suggests HIF-1α may serve as a biomarker for COPD airway changes.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Pathology
Background:
- Airway remodeling is a key feature of chronic obstructive pulmonary disease (COPD).
- The role of hypoxia-inducible factor 1-alpha (HIF-1α) in COPD airway remodeling is not well understood.
- Investigating HIF-1α could reveal new therapeutic targets for COPD.
Purpose of the Study:
- To examine HIF-1α expression in COPD patients.
- To determine the association between HIF-1α and airway remodeling in COPD.
- To explore HIF-1α as a potential biomarker for COPD airway remodeling.
Main Methods:
- Included 60 COPD patients and 28 controls.
- Used immunohistochemistry to assess HIF-1α and MMP9 expression in airway tissue.
- Measured serum HIF-1α and MMP9 via ELISA.
- Analyzed CT scan parameters for airway remodeling.
Main Results:
- COPD patients showed significant airway remodeling, including fibrosis.
- Elevated HIF-1α and MMP9 levels were observed in COPD airway tissue and serum.
- CT scans confirmed airway remodeling and increased airway parameters in COPD patients.
Conclusions:
- Increased HIF-1α expression is linked to airway remodeling in COPD.
- HIF-1α shows potential as a biomarker for COPD airway remodeling.
- Findings may guide future therapeutic strategies for COPD.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

